NOVACYT FULL YEAR 2015 RESULTS Delivers strong double-digit sales growth Completes transformational strategic acquisition

Novacyt FY15 financial results PR ENGLISH

Paris, France and Cambridge, UK – 12 May 2016 – Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics, today announces the completion of the strategic acquisition of Primer Design Limited and audited financial results for the year ended 31st December 2015, approved by the Board of Directors on 10 May 2016.